1998
DOI: 10.1007/s004150050271
|View full text |Cite
|
Sign up to set email alerts
|

Neurological complications of radiotherapy and chemotherapy

Abstract: Neurological complications of radiotherapy and chemotherapy can affect the central or peripheral nervous system. Most are dose-dependent and constitute a limiting factor in the administration of treatments. Radiation-induced neurological complications are classified as acute, early-delayed or delayed. The most important are radionecrosis and cognitive dysfunction/leukoencephalopathy. Neurotoxicity of chemotherapy is frequent and depends upon dose, type of drugs (especially cisplatin and methotrexate) and their… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
130
0
4

Year Published

2001
2001
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 228 publications
(136 citation statements)
references
References 65 publications
1
130
0
4
Order By: Relevance
“…In medicine, a possible neuropathy following the treatment of cancer by MT-stabilizing drugs such as paclitaxel or docetaxel is a well-known phenomenon [188] and presumably linked to the breakdown of axonal transport [122]. Recently, in vivo experimental imaging has shown that the breakdown of MT dynamics induced by the injection of paclitaxel indeed coincides with the breakdown of vesicle transport [343].…”
Section: Discussionmentioning
confidence: 99%
“…In medicine, a possible neuropathy following the treatment of cancer by MT-stabilizing drugs such as paclitaxel or docetaxel is a well-known phenomenon [188] and presumably linked to the breakdown of axonal transport [122]. Recently, in vivo experimental imaging has shown that the breakdown of MT dynamics induced by the injection of paclitaxel indeed coincides with the breakdown of vesicle transport [343].…”
Section: Discussionmentioning
confidence: 99%
“…The adverse effects of radiation to the brain, both as primary CNS therapy and prophylactic treatment, have been previously reviewed in detail (Crossen et al, 1994;Keime-Guibert et al, 1998). The development of neurologic and/or neuropsychological dysfunction is often the greatest dose-limiting factor of radiotherapy (XRT).…”
Section: Radiotherapymentioning
confidence: 99%
“…[1][2][3][4] Neuropsychological deficits (diminished cognitive performance), especially in terms of attention and memory, are attracting increasing attention.…”
Section: Introductionmentioning
confidence: 99%